aod9604 recommended dosage PDF) Peptides: AOD-9604 & BPC-157 What is AOD 9604 Peptide?
Description
The changes are most noticeable in areas with higher beta-3 adrenergic receptor density: the lower abdomen, flanks, and visceral fat compartments
For research use only
Research protocols for AOD-9604 typically involve relatively small daily doses
effect blocked by lipase inhibitor orlistat
This selectivity is both the appeal and the limitation
Ignoring the role of nutrition undermines peptide protocols regardless of dose
